General medical journalCurrentEndo coverage
The BMJ
What CurrentEndo has captured from this journal. The coverage figures describe CurrentEndo's coverage, not the journal's output. Figures as of 14 November 2026.
CurrentEndo holds 39 Briefs from The BMJ, most often cohort studies and meta-analyses.
Follow all of it, or only:You follow this. See your week →Explore BMJ with filters →
- Recent
- 4 Briefs
- past 90 days
- Archive
- 39 Briefs
- research published Jul 2025 – today, Jan 2024 – Mar 2025 and Apr–Jun 2023
- Editorial
- –
- no Weekly issue published yet
Topics
Evidence types
- Randomized controlled trials615.4%
- Meta-analyses923.1%
- Cohort studies1948.7%
- Case-control studies25.1%
- Guidelines & statements12.6%
- Other research25.1%
Shares are of the 39 Briefs CurrentEndo has covered from BMJ, by primary topic and study type.
Publication activity
- 202611 Briefs
- 20258 Briefs
- 202415 Briefs
- 20235 Briefs
Latest from The BMJ
BMJ
BMJ
Contemporary menopausal hormone therapy and thrombotic disease: nationwide nested case-control study
Case-control studyReproductive endocrine
BMJ
BMJ
BMJ
Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study
Cohort studyComplications
BMJ
BMJ
BMJ
BMJ
Menopausal hormone therapy and long term mortality: nationwide, register based cohort study
Cohort studyReproductive endocrine
BMJ
BMJ
Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis
Meta-analysisDiabetes in pregnancy
BMJ
BMJ
BMJ
Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline
Guideline or statementT2D & other
BMJ
BMJ
BMJ
BMJ
BMJ
Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial
Randomized controlled trialT2D & other
BMJ
BMJ
Chocolate intake and risk of type 2 diabetes: prospective cohort studies
Cohort studyT2D & other
BMJ
Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial
Cohort studyReproductive endocrine
BMJ
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial
Randomized controlled trialReproductive endocrine
BMJ
BMJ
BMJ
Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial
Randomized controlled trialT2D & other
BMJ
BMJ
BMJ
BMJ
BMJ
BMJ
Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study
Cohort studyEndocrine cancer
BMJ
BMJ
BMJ
Menopausal hormone therapy and dementia: nationwide, nested case-control study
Case-control studyReproductive endocrine
BMJ
BMJ
BMJ
Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study
Cohort studyBone & mineral
BMJ